Medaudio-Optica S.R.L.
- Address
- lock Available on a paid plan
Medaudio-Optica S.R.L. - Autoimmune and Rheumatic Disease Research Center
Medaudio-Optica S.R.L. is a specialized clinical research center with extensive expertise in autoimmune and rheumatologic conditions. The center has demonstrated particular proficiency in conducting Phase 3 trials for novel therapeutic agents targeting complex immune-mediated diseases, with a strong focus on evaluating both biologic-naïve and biologic-experienced patient populations.
- Psoriatic arthritis research, including studies in adult and juvenile populations with varying treatment histories
- Systemic lupus erythematosus (SLE) trials evaluating novel oral and biologic therapies
- Sjögren's syndrome and systemic sclerosis investigations
- Axial spondyloarthritis, rheumatoid arthritis, and osteoarthritis clinical programs
The center's research portfolio encompasses a diverse range of disease-modifying anti-rheumatic drugs (DMARDs), including innovative JAK inhibitors, TYK2 inhibitors, and S1P receptor modulators. With experience in both interventional efficacy trials and long-term safety extension studies, Medaudio-Optica S.R.L. contributes valuable data on pharmacokinetics, biosimilar comparability, and the evaluation of emerging therapeutic targets in autoimmune rheumatic diseases. Their participation in international multicenter trials demonstrates their capability in managing complex study protocols and diverse patient populations with moderate to severe disease manifestations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medaudio-Optica S.R.L.
lock Showing 1 of 14 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 randomized, placebo-controlled, double-blind, parallel-group program to evaluate efficacy and safety of filgotinib in adult subjects with active axial spondyloarthritis | Alfasigma S.p.A. | Phase III | Not Recruiting | Jun 2023 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Deucravacitinib | 3 | Unknown | 2021-10-20 | 2025-02-28 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.